ITGA2B and breast carcinoma: Thus, it is reasonable to assume that the increased activation of platelets observed at advanced stages of breast cancer development may be associated with elevated fractions of procoagulant platelets, which may demonstrate increased expression of the inactivated GPIIb/IIIa complex.